Nanofiltration of factor VII solutions to remove virus

Details for Australian Patent Application No. 2004294403 (hide)

Owner Novo Nordisk Health Care AG

Inventors Halkjaer, Erik; Hansen, Thomas Budde; Johansen, Nina; Preuss, Turid; Christensen, Jesper; Tomoda, Lene Vaedele Madsen

Agent Shelston IP

Pub. Number AU-A-2004294403

PCT Pub. Number WO2005/054275

Priority PA 2003 01775 01.12.03 DK

Filing date 1 December 2004

Wipo publication date 16 June 2005

International Classifications

C07K 1/34 (2006.01) General processes for the preparation of peptides

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C12N 7/06 (2006.01) Viruses, e.g. bacteriophages

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054275 Priority application(s): WO2005/054275

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294404-Railway beacon and related production method

2004294377-Protein NMB0928 and use thereof in pharmaceutical formulations